INTERNATIONAL PATENT: OHIO STATE INNOVATION FOUNDATION FILES APPLICATION FOR "HUMANIZED SCFV ANTIBODY TARGETING THE PROXIMAL REGION OF CD30 FOR ANTI-CANCER CELLULAR THERAPY"

GENEVA, June 18 -- OHIO STATE INNOVATION FOUNDATION (1524 North High StreetColumbus, Ohio 43201) filed a patent application (PCT/US2024/058063) for "HUMANIZED SCFV ANTIBODY TARGETING THE PROXIMAL REGION OF CD30 FOR ANTI-CANCER CELLULAR THERAPY" on Dec 02, 2024. With publication no. WO/2025/122420, the details related to the patent application was published on Jun 12, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): DENLINGER, Nathan (1524 North High StreetColumbus, Ohio 43201), CHAN, Wing (1524 North High StreetColumbus, Ohio 43201)

Abstract: Disclosed herein is a fully humanized single ch...